BioAro Announces Real Time DNA Decoding Technology

Stock.adobe.com

Human genome sequencing is about to get faster.

Genomic research and technology company BioAro announced that it is launching new software that is capable of real-time genomic analysis.¹ PanOmiQ is billed as the fastest technology of its kind, and it will launch on May 9, 2024, at the Precision Medicine Expo in Dubai.

The technology is part of the company’s precision health inititative.

In a press release, BioAro founder and CEO Dr. Anmol S. Kapoor said, “Our team at BioAro are committed to pushing the boundaries of genomic research and technology through real-time genomic testing and analysis to provide enhanced quality of life and Healthspan. With the launch of PanOmiQ, we are ushering in a new era of precision medicine, where every patient receives tailored treatments based on their unique genetic makeup."

In the same press release, the company’s chief scientific officer Dr. Raja B. Singh said, “Turnaround time in genomic analysis is critical, and this is where PanOmiQ comes in with its unmatched speed and accuracy. The proprietary AI- platform also provides clinical annotations and helps better understand disease risk."

The software utilizes AI-powered technology and is capable of decoding DNA sequences in real-time. According to BioAro, this will allow healthcare providers make informed decisions on a much shorter timeline.

Dr. Minal Borkar Tripathi, Director of Genomics at BioAro, said, "With the power of artificial intelligence, PanOmiQ helps identify rare diseases, health predispositions, and pharmacogenomic insights with unmatched speed and precision. Its ability to provide Pharmacogenomic analysis is a major advancement in tailoring treatment for optimal patient care."

In February, BioAro announced that Raman Kapoor would lead its precision health, healthspan, and longevity initiatives.² In a press release issued at the time, CEO Dr. Anmol Kapoor said, “Raman Kapoor's expertise will be instrumental in aligning BioAro's goals with the evolving landscape of healthcare. Her appointment as Chief HealthSpan Officer marks a significant milestone for BioAro as her leadership will guide us in pioneering innovative solutions that not only benefit our employees but contribute to the global well-being.”

In the same press release, Raman Kapoor said, “"I am honored to join BioAro as the world's first Chief HealthSpan Officer. This role presents an exciting opportunity to contribute to the company's mission of advancing precision health, healthspan, and longevity for a healthier and more vibrant world."

Other senior members of the BioAro shared their thoughts on the new position at the time as well. The company’s chief scientific officer Dr. Raja Singh said that Kapoor would be essential in moving the company’s scientific endeavors closer to breakthroughs. Singh also believed that this showed the company’s dedication to precision medicine research.

BioAro defines healthspan as the time that a person is healthy and free of chronic diseases. This conditions often bring about serious and often debilitating side effects that impact patients’ abilities to live normal lives. By focusing on healthspan initiatives, BioAro is hoping to increase the amount of time that patients are able to live free of these serious conditions.

Source

1. BioAro Announces a Medical and Computing Breakthrough by Launching the 'World's Fastest' Real-Time Genomic Software 'PanOmiQ.' BioAro Inc. April 25, 2024. https://www.prnewswire.com/news-releases/bioaro-announces-a-medical-and-computing-breakthrough-by-launching-the-worlds-fastest-real-time-genomic-software-panomiq-302127201.html
2. BioAro Welcomes World's First Chief HealthSpan Officer, Raman Kapoor to Lead Precision Health, HealthSpan, and Longevity Initiatives. BioAro inc. February 13, 2024. Accessed April 25, 2024. https://www.prnewswire.com/news-releases/bioaro-welcomes-worlds-first-chief-healthspan-officer-raman-kapoor-to-lead-precision-health-healthspan-and-longevity-initiatives-302060172.html